These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16170024)

  • 41. Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells.
    Weng D; Song X; Xing H; Ma X; Xia X; Weng Y; Zhou J; Xu G; Meng L; Zhu T; Wang S; Ma D
    Cancer Lett; 2009 Jan; 273(2):257-65. PubMed ID: 18842333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro antitumor properties of a novel cyclin-dependent kinase inhibitor, P276-00.
    Joshi KS; Rathos MJ; Joshi RD; Sivakumar M; Mascarenhas M; Kamble S; Lal B; Sharma S
    Mol Cancer Ther; 2007 Mar; 6(3):918-25. PubMed ID: 17363486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Molecular mechanism of anti-apoptotic action of survivin in NCI-H446 lung cancer cells].
    Chen Y; Li W; Zhou JH; Li DM; Xia XM; Huang LN; Li BQ
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):413-7. PubMed ID: 17152484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variation in the kinetics of caspase-3 activation, Bcl-2 phosphorylation and apoptotic morphology in unselected human ovarian cancer cell lines as a response to docetaxel.
    Kolfschoten GM; Hulscher TM; Duyndam MC; Pinedo HM; Boven E
    Biochem Pharmacol; 2002 Feb; 63(4):733-43. PubMed ID: 11992642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer.
    Salzano G; Navarro G; Trivedi MS; De Rosa G; Torchilin VP
    Mol Cancer Ther; 2015 Apr; 14(4):1075-84. PubMed ID: 25657335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Signaling network of paclitaxel-induced apoptosis in the LNCaP prostate cancer cell line.
    Panvichian R; Orth K; Pilat MJ; Day ML; Day KC; Yee C; Kamradt JM; Pienta KJ
    Urology; 1999 Oct; 54(4):746-52. PubMed ID: 10510942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of roscovitine, a selective CDK inhibitor, on cancer cells: bi-functionality increases its therapeutic potential.
    Wesierska-Gadek J; Borza A; Komina O; Maurer M
    Acta Biochim Pol; 2009; 56(3):495-501. PubMed ID: 19724778
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.
    Wall NR; O'Connor DS; Plescia J; Pommier Y; Altieri DC
    Cancer Res; 2003 Jan; 63(1):230-5. PubMed ID: 12517802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
    Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis.
    Jazirehi AR; Bonavida B
    Mol Cancer Ther; 2004 Jan; 3(1):71-84. PubMed ID: 14749477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells.
    Deep G; Oberlies NH; Kroll DJ; Agarwal R
    Carcinogenesis; 2007 Jul; 28(7):1533-42. PubMed ID: 17389612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy.
    Sharma H; Sen S; Lo Muzio L; Mariggiò A; Singh N
    Cancer Biol Ther; 2005 Jul; 4(7):720-7. PubMed ID: 15917659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Alteration of survivin gene expression in ovarian cancer cell line CAOV3 after chemotherapy in vitro].
    Zhang SL; Jiang T; Lin B; Zhao CQ; Meng LR
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):482-5. PubMed ID: 15347474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT.
    Chao JI; Su WC; Liu HF
    Mol Cancer Ther; 2007 Nov; 6(11):3039-48. PubMed ID: 18025287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
    McKay TR; Bell S; Tenev T; Stoll V; Lopes R; Lemoine NR; McNeish IA
    Oncogene; 2003 Jun; 22(23):3539-47. PubMed ID: 12789262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitization of cervical carcinoma cells to paclitaxel by an IPP5 active mutant.
    Zeng QY; Huang Y; Zeng LJ; Huang M; Huang YQ; Zhu QF
    Asian Pac J Cancer Prev; 2014; 15(19):8337-43. PubMed ID: 25339026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
    Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
    Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel.
    Kar R; Palanichamy JK; Banerjee A; Chattopadhyay P; Jain SK; Singh N
    Clin Transl Oncol; 2015 Sep; 17(9):737-42. PubMed ID: 26033427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A p34(cdc2) survival checkpoint in cancer.
    O'Connor DS; Wall NR; Porter AC; Altieri DC
    Cancer Cell; 2002 Jul; 2(1):43-54. PubMed ID: 12150824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel combination: ranpirnase and rosiglitazone induce a synergistic apoptotic effect by down-regulating Fra-1 and Survivin in cancer cells.
    Ramos-Nino ME; Littenberg B
    Mol Cancer Ther; 2008 Jul; 7(7):1871-9. PubMed ID: 18606715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.